BIODANE PHARMA A/S: Financial statements 2018
CVR: 28310102
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,010,830 and a net result of DKK -467,077 compared with DKK 102,788 the year before. That is an increase of 4.5% compared with the year before. Equity in the 2018 report amounted to DKK 1,402,228. The solvency ratio was 95%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,010,830
- Profit/Loss
- DKK -467,077
- Equity
- DKK 1,402,228
- Total Assets
- DKK 1,476,565
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1 mio. | -467 t. | 1.4 mio. | 1 |
| 2017 | - | 968 t. | 103 t. | 1.9 mio. | 1 |
| 2016 | - | 747 t. | 33 t. | 767 t. | 1 |
| 2015 | - | 438 t. | -253 t. | 734 t. | - |
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIODANE PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 967,640, and the net result was DKK 102,788.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named BIODANE PHARMA ApS and BIOFIBER TØRRING ApS. The management consists of Gunner Kreutzer Jakobsen. The board consists of Peter Gæmelke (chair), Flemming Torben Heden Knudsen, Gunner Kreutzer Jakobsen and Rasmus Juhl Rasmussen. The company is owned by BIODAN A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity in the 2025 report amounted to DKK 2,505,002.